Background -Major depressive disorder and sub-threshold depression have been associated
Introduction
Several systematic reviews have shown that a diagnosis of major depressive disorder 
2005)
, so limiting insights into the "shape" of the depressive symptom-mortality relation (i.e.,
dose-response versus threshold).
We undertook an analysis of the association between depressive symptoms and mortality across the full range of severity of depressive symptoms in the English Longitudinal Study of Ageing, a large, well-characterized, community-based cohort study of older adults. We hypothesized that the association between depressive symptoms and the risk of all-cause mortality would emerge at a severity below current thresholds for identifying clinically relevant symptoms of depression. 
Methods

We used data from the English Longitudinal Study of Ageing (ELSA)
.
Measurement of Depressive Symptoms
During the 2002/03 household visit, information was collected on depressive symptoms using a computer assisted personal interview. Depressive symptoms were measured using the eight- 
Measurement of Covariates
From the 2002/3 interview we obtained information on social, demographic, clinical, and lifestyle covariates using a computer assisted personal interview. Socioeconomic position was based on the National Statistics Socio-economic Classification (NS-SEC) classification system (Rose & Pevalin 2003). A wealth score was based on the sum of all financial, physical (businesses, land) and housing wealth, minus debts and pension payments (Banks et al.
2006
). Cohabitation status was defined as currently living alone or not. Self-reported health behaviors included smoking status (current, ex-smoker, and never), frequency of alcohol consumption in the past year (not at all, on special occasions, once or twice a month, once or twice a week, daily, ≥ 2 times a day), and physical activity during leisure time, recorded as participation in vigorous, moderate, and mild activities (more than once per week, once per week, one to three times per month, hardly ever) (Hamer et al. 2009 ).
Measures of health included lifetime self-reported doctor diagnoses of chronic somatic conditions (chronic obstructive pulmonary disorder [COPD], asthma, diabetes, and arthritis), circulatory disease (hypertension, prior heart attack, stroke, angina), heart conditions (murmur, abnormal heart rhythm), depression and cancer. The use of Functional impairments were assessed by asking participants whether they experienced difficulties, for at least three months, with six activities of daily living (ADL) and seven instrumental activities of daily living (IADL; Steel et al. 2004 ). Participants reporting one or more problems with an ADL or IADL were classified as having a functional impairment.
Mortality ascertainment
All-cause mortality was ascertained for a nine year period for consenting study members (11,104; 97.5% of eligible participants) by linking to the UK National Health Service mortality register up to until the 15 th March 2012. In the UK, registration of death within 5 days is a legal requirement so participants not registered as dead were assumed to be alive.
Statistical Analysis
The characteristics of participants were compared according to the severity of their depressive symptoms using the chi-square test and analysis of variance. We then used Cox proportional hazards models (Cox 1972), with accompanying 95% confidence intervals, to estimate the association between depressive symptoms and mortality. We ascertained that the proportional hazards assumption had not been violated by inspecting the log (−log(survival)) plot and Schoenfeld residuals. Participants scoring 0 on the CES-D were regarded as being free of depressive symptoms and this was our reference group. We compared this reference group with those participants scoring in each of the remaining eight groups, plotted KaplanMeier survival curves for each group, and also reported HRs per standard deviation increase in depressive symptoms (standard deviation: 2.00).
Survival time was measured in months from the date of interview to date of death or the 15th March 2012 -which ever came first. Emigrants were included in analyses with the date of their last interview as their censoring date. In preliminary analyses, there was no evidence that the association between depressive symptoms and mortality was modified by sex, so data for men and women were pooled and analyses sex-adjusted. We also took into 
Sensitivity Analysis
We conducted several planned sensitivity analyses. We compared people with data missing for one or more variables with those with complete data using t-tests and the χ 2 test. The proportion of missing data from item non-response was then imputed using multiple imputation by chained equations which included all variables (including mortality) in the prediction model using the ice command in Stata v.13 to generate 10 imputed datasets (White et al. 2011). To examine the effect of imputing data on the association between depressive symptoms and mortality we ran our analysis in a sample with no missing data (n= 10,131 were found in study members at opposing ends of the continuum of depressive symptoms.
Of the 11,104 participants in the ELSA, 2,267 (20.4%) died during a mean follow-up of 9.1 years (SD = 2.3). Figure 1 shows a positive trend was found with more severe depressive symptoms associated with a higher rate of mortality (P for trend <0.001). After adjustment for socioeconomic position, the strength of the association between depressive symptoms and mortality (HR per one SD disadvantage) reduced from 1.26 in the basic model (age-, sex-and ethnicity-adjusted) to 1.20, representing 23% attenuation in risk. The greatest reduction in HRs occurred after adding health behaviors to the model (a 62% reduction compared to basic model), followed by functional impairments (54%) and physician diagnoses (23%), although after these separate adjustments the trend remained statistically significant the P <0.001 level. After full adjustment, the positive association between symptom severity and mortality was effectively eliminated (100% attenuation, P for trend= 0.25, Figure 1 and Supplementary Table S1 ). Of the factors entered into the multivariable model, physical activity and functional impairments alone accounted for 73% of the depressive symptom-mortality association.
The unadjusted Kaplan Meir failure curve (Figure 2 ), 95% CIs for the HRs for a CES-D score of 0 to 8 (Supplementary Table S1 ) and survival curve (Supplementary Figure S1) suggest there is a threshold in the association between depressive symptoms and mortality.
Although the HRs increase with symptom severity there is not a statistically significant increase in risk after a score of two (log rank for a score of <2 vs. ≥2 = 2416.87; P<0.001). Figure 2 shows that by 70 years of age 10% of people with a depressive symptom score ≥2
had died, a mortality rate that is not reached until age 75 years in those with a depressive symptom score <2.
Data were missing for one or more variables for 8.8% (n=973) of the sample.
Compared to those study members who featured in the analytical sample, people with missing data were more likely to be older, female, non-white, be in the lowest quintile for wealth, live alone, have had a heart attack, stroke, have diabetes, a heart condition, be inactive at mild, moderate or vigorous intensities, have a functional impairment, but less likely to drink heavily, or have smoked. However, no more likely to have angina, cancer, arthritis, COPD, asthma, be in a lower social class, or report using antidepressants. We examined the impact on our main estimates of missing data by repeating the analysis in participants without any missing data (n= 10,131). The results were comparable to those in the main analysis (age, sex-and ethnicity-adjusted HR per SD disadvantage with imputed data was 1.26, 95% CI = 1.22-1.31; the HR in sample without any missing data was 1.25, 95% CI = 1.21-1.31; Supplementary Table S1 and S3). We also re-ran our analysis after removing items from the depressive symptom scale relating to somatic symptoms. The association between depressive symptoms and mortality was slightly attenuated after removing somatic symptoms, but the trend remained significant (P<0.001, Supplementary Table S4) .
Sub-group analysis
We excluded 982 deaths which occurred within the first five years of follow-up to test for reverse causality. These exclusions slightly reduced the strength of the association between depressive symptoms and mortality, but replicated the trend found in the main analysis (Supplementary Table S5 ).
Discussion
The main finding in this study was an association between depressive symptoms across the full range of severity and all-cause mortality. We found that even in people with low to moderate symptom scores that they would not usually bring them to the attention of mental health services, experienced an increased risk of mortality. Excluding deaths occurring in the first five years of follow-up produced only a modest attenuation of the association suggesting it may be partially attributable to reverse cause. Adjustment for a wide range of potential confounding factors, including levels of physical inactivity, cognitive function, impairments and physical illnesses fully attenuated the association.
We identified seven cohort studies that had examined the association between such that the association between depressive symptoms, antidepressants and mortality is unclear. In the present study, adjustment for antidepressant had essentially no effect on risk estimates, suggesting antidepressant use is unlikely to explain the association between mortality and depressive symptoms.
The main strength of this study is that it is with a nationally-representative sample, In this large prospective study of men and women aged over 50 years, depressive symptoms were associated with an increased risk of mortality, even at low-levels of symptom severity. Levels of physical inactivity, cognitive function, functional impairments and physical illnesses fully attenuated this association. A third of older adults had symptoms at a severity associated with an increased risk for mortality, and one in ten scored under validated cut-points for clinically significant depressive symptoms but experienced an increased risk for all-cause mortality, suggesting current cut-points do not identify one in ten people at an increased risk for early death.
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The Depressive symptom score 24 depressant medication, and health behaviors (white). The reference group are participants with a score of zero; a higher score indicates more severe depressive symptoms. f Chronic conditions were COPD and other chronic respiratory conditions, asthma, diabetes (types 1 and 2) and arthritis;
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